622 filings
Page 7 of 32
4
qcj5fi7a vs2r
17 Sep 21
NeuBase Therapeutics / ERIC I RICHMAN ownership change
4:16pm
424B5
yz0kgk hgm
27 Aug 21
Prospectus supplement for primary offering
5:21pm
8-K
yjb222nceuh
27 Aug 21
Entry into a Material Definitive Agreement
12:00am
8-K
5kne9xw 7j8
19 Aug 21
Submission of Matters to a Vote of Security Holders
8:00am
8-K
kuw ele9zwr2tkyi546r
12 Aug 21
NeuBase Therapeutics Reports Financial Results for the Third Quarter of Fiscal Year 2021 and Recent Operating Highlights
4:18pm
EFFECT
5kk h5gifn5
8 Jul 21
Notice of effectiveness
12:15am
424B3
44b7g
7 Jul 21
Prospectus supplement
5:16pm
DEFA14A
1gaifaldfmaoy7hb6g
2 Jul 21
Additional proxy soliciting materials
7:06am
CORRESP
eka0 mzt3q
2 Jul 21
Correspondence with SEC
12:00am
UPLOAD
676ty1py5xx rtad0j
1 Jul 21
Letter from SEC
12:00am
4
yxz4syvv
21 Jun 21
NeuBase Therapeutics / DOV A MD GOLDSTEIN ownership change
11:03am
8-K
8o9q3
8 Jun 21
Regulation FD Disclosure
2:01pm
4
lu0g63j9rwyt62e4l
25 May 21
NeuBase Therapeutics / Sandra Rojas-Caro ownership change
4:13pm
4
frobb jk4f06
25 May 21
NeuBase Therapeutics / Kianoush Motesharei ownership change
4:12pm
3
71342x7p6tspruty5zm
25 May 21
NeuBase Therapeutics / Sandra Rojas-Caro ownership change
4:10pm
3
1wk e2uxtpip47oo
25 May 21
NeuBase Therapeutics / Kianoush Motesharei ownership change
4:10pm
8-K
3tz4jeu1o3
25 May 21
NeuBase Therapeutics Appoints Dr. Kia Motesharei Chief Business and Strategy Officer
9:00am